Clinical Trial Update: Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adding a long-acting injectable to a multi-drug regimen for non-tuberculous mycobacterial infections; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Infections
• Non-tuberculous Mycobacterial Infection

Drugs mentioned

• Insmed Incorporated
• LAI
• Multi-drug regimen

Snippet

Sponsor: Insmed Incorporated | Conditions: Mycobacterium Infections, Nontuberculous | Phase 3 | Status: COMPLETED | Results posted: 2018-11-20